Abstract:
PURPOSE: A composition containing a Zinnia elegans extract for preventing or treating BSE(bovine spongiform encephalopathy) is provided to suppress abnormal prion, and to be used as an eco-friendly preservative or therapeutic agent for BSE. CONSTITUTION: A veterinary composition for preventing or treating BSE contains a Zinnia elegans extract. The extract is prepared using a solvent selected from a group consisting of water, C1-C4 alcohol, and a mixture thereof. The concentration of the extract is 12.5 microgram/ml. A feed additive composition for preventing or treating BSE contains the extract. A feed composition for preventing or treating BSE contains the extract.
Abstract:
본 발명은 사슴의 PrP 펩타이드 중 특정부위를 선발하여 이를 유전자 적중 마우스에 접종하여 면역시킨 후 여기에서 분리한 면역 B 세포와 마우스 골수종유래세포를 융합하여 제조한 융합세포주; 상기 융합세포주로부터 생산되고 사슴만성소모성질병의 변형프리온(PrP sc )을 사슴의 정상프리온 및 소해면상뇌증 및 스크래피(Scrapie) 등의 다른 전염성해면상뇌증의 변형프리온과 감별하여 검출해 내는 단클론항체 및 그 용도에 관한 것이다. 사슴만성소모성질병, 변형프리온, 단클론항체, 융합세포주, PrP 펩타이드, 전염성해면상뇌증
Abstract:
PURPOSE: A method for preparing TSE(transmissible spongiform encephalopathy) sensitive cells is provided to develop novel drugs. CONSTITUTION: A method for preparing TSE-sensitive cells comprises: a step of isolating normal prion protein gene from the brain of an animal which infected by TSE and cloning; a step of inserting the gene to a lentivirus transfer vector to prepare infectious recombinant lentivirus; and a step of inoculating the infectious recombinant lentivirus to non-animal mammal cell line to prepare transformed cells which express a normal prion protein.